more press coverage...2 May 2020 18:45
….Daily mail today...
Stock Watch - Genedrive
Investors cheered as Genedrive completed its pilot batch of coronavirus testing kits, which it has developed with partner Cytiva.
Having cleared the final manufacturing hurdle, Genedrive is hoping the test will get approval from EU regulators – known as CE marking – in around three weeks’ time.
The test that Manchester-based Genedrive is making would deliver a quick result without needing to be sent to a lab.
Shares surged 24.3 per cent, or 26.5p, to 135.5p.